7 pm Monday 12 June on Zoom
It has been a new dawn in bespoke medical therapies for thyroid eye disease since the FDA approval of Teprotumumab in the USA.
BOPSS have assembled a panel of TED Trial Investigators and other experts who can share their experiences and perspectives, to encourage wider UK participation and increase patient access to these exciting new therapies in the blossoming trial landscape.